Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Ehst · SciRah

Researcher profile · Semantic Scholar

B. Ehst

Share profile

B. Ehst — researcher profile on SciRah

h-index: 19
Works: 69
Citations: 3,264

Most-cited papers

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.
A. Itano, S. McSorley, R. Reinhardt, B. Ehst +3 more
2003Immunity810 citations Open access
Semantic Scholar
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Edith M. Janssen, N. Droin, E. Lemmens, M. Pinkoski +5 more
2005Nature652 citations
Semantic Scholar
Bacterial Flagellin Is an Effective Adjuvant for CD4+ T Cells In Vivo1
S. McSorley, B. Ehst, Yimin Yu, A. Gewirtz
2002Journal of Immunology292 citations Open access
Semantic Scholar
CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
Anne I. Sperling, Julie A. Auger, B. Ehst, Ingrid C Rulifson +2 more
1996Journal of Immunology263 citations
Semantic Scholar
Development of a Novel Transgenic Mouse for the Study of Interactions Between CD4 and CD8 T Cells During Graft Rejection
B. Ehst, E. Ingulli, M. Jenkins
2003American Journal of Transplantation236 citations Open access
Semantic Scholar
Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
J. Pérez-Rodríguez, S. Lai, B. Ehst, D. Fine +1 more
2009Radiology214 citations Open access
Semantic Scholar
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
M. Lebwohl, L. S. Stein Gold, B. Strober, K. Papp +13 more
2021New England Journal of Medicine151 citations
Semantic Scholar
Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum
Margaret A. Fonder, Deborah L. Cummins, B. Ehst, G. Anhalt +1 more
2006Journal of burns and wounds75 citations
Semantic Scholar
Indirect Minor Histocompatibility Antigen Presentation by Allograft Recipient Cells in the Draining Lymph Node Leads to the Activation and Clonal Expansion of CD4+ T Cells That Cause Obliterative Airways Disease1
D. Richards, Stacy L. Dalheimer, B. Ehst, Tracy L. Vanasek +3 more
2004Journal of Immunology58 citations
Semantic Scholar
Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review
A. Blauvelt, A. Chiricozzi, B. Ehst, M. Lebwohl
2023Advances in Therapy51 citations Open access
Semantic Scholar
Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis
B. Truong, N. Rich-Garg, B. Ehst, A. Deodhar +4 more
2015Clinical, Cosmetic and Investigational Dermatology44 citations Open access
Semantic Scholar
Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Anisha B. Patel, A. R. Solomon, M. Mauro, B. Ehst
2015Dermatology39 citations
Semantic Scholar
Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes
B. Ehst, Zhiping Wang, J. Leitenberger, D. McClanahan +7 more
2020Cytokine31 citations Open access
Semantic Scholar
Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib.
Alexander R Jack, M. Mauro, B. Ehst
2013Journal of American Academy of Dermatology27 citations
Semantic Scholar
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.
C. Varley, A. Deodhar, B. Ehst, A. Bakke +4 more
2014Rheumatology26 citations
Semantic Scholar
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
L. S. Gold, April W. Armstrong, R. Bissonnette, N. Magnolo +26 more
2025The Lancet25 citations Open access
Semantic Scholar
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis
A. Menter, T. Bhutani, B. Ehst, B. Elewski +1 more
2022Dermatologic Therapy25 citations Open access
Semantic Scholar
Cutaneous manifestations of internal malignancy.
B. Ehst, Karen Minzer-Conzetti, A. Swerdlin, T. S. Devere
2010Current problems in surgery24 citations
Semantic Scholar
Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin.
B. Ehst, E. Warshaw
2004Archives of Dermatology19 citations
Semantic Scholar
A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic
N. Garg, B. Truong, J. Ku, T. S. Devere +3 more
2015Clinical Rheumatology18 citations
Semantic Scholar
Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.
B. Ehst, B. Dréno, E. Vonderheid
2008EJD. European journal of dermatology15 citations
Semantic Scholar
Secukinumab in adult patients with lichen planus: Efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study.
T. Passeron, Maximilian Reinhardt, B. Ehst, Jonathan S. Weiss +10 more
2024British Journal of Dermatology14 citations Open access
Semantic Scholar
Ustekinumab use in patients with severe psoriasis co‐infected with hepatitis B and/or C
S. Siegel, K. Winthrop, B. Ehst, A. O. Loayza
2019British Journal of Dermatology14 citations
Semantic Scholar
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
E. Guttman-Yassky, K. Kabashima, Margitta Worm, Paula Luna +18 more
2025The Lancet12 citations
Semantic Scholar
Triple antibiotic combination therapy may improve but not resolve granuloma annulare
B. Simpson, S. Foster, J. Ku, E. Simpson +1 more
2014Dermatologic Therapy12 citations Open access
Semantic Scholar
Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents
J. Curtis, M. Danila, Lang Chen, B. Chan +4 more
2016Journal of Psoriasis and Psoriatic Arthritis11 citations Open access
Semantic Scholar
Nicolau syndrome and localized panniculitis: a report of dual diagnoses with an emphasis on morphea profunda‐like changes following injection with glatiramer acetate
S. Mott, Zachary G. Peña, Rebecca I. Spain, Kevin P. White +1 more
2016Journal of cutaneous pathology11 citations
Semantic Scholar
A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Renato Goreshi, A. Samrao, B. Ehst
2012Journal of Drugs in Dermatology11 citations
Semantic Scholar
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials
L. S. Gold, J. D. Del Rosso, B. Ehst, M. Zirwas +5 more
2025Journal of dermatological treatment (Print)9 citations Open access
Semantic Scholar
A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis
B. Ehst, B. Strober, A. Blauvelt, D. Maslin +4 more
2024Frontiers in Medicine9 citations Open access
Semantic Scholar
Toll‐like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T‐cell lymphoma
Anne-Chantal Knol, B. Ehst, A. Dompmartin, G. Quereux +6 more
2009British Journal of Dermatology8 citations
Semantic Scholar
Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16
E. Song, B. Ehst, B. Glick, G. Lewitt +11 more
2025Dermatologic Therapy7 citations Open access
Semantic Scholar
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab
A. Blauvelt, Run-Dong Jiang, Linyu Shi, L. Tsoi +8 more
2025Nature Communications7 citations Open access
Semantic Scholar
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States
J. Silverberg, David E. Cohen, E. Guttman-Yassky, L. Eichenfield +8 more
2026American Journal of Clinical Dermatology6 citations Open access
Semantic Scholar
15354 Response to treatment with secukinumab in obese patients with moderate to severe psoriasis
J. Krueger, D. Pariser, E. Muscianisi, F. Kianifard +4 more
20205 citations
Semantic Scholar
Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream
Timo Buhl, Andrea Bauer, B. Ehst, J. Thyssen +4 more
2025Dermatologic Therapy4 citations Open access
Semantic Scholar
Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double-Blind, Phase 3 Trials
R. Bissonnette, Fatima Albreiki, B. Ehst, A. Al Hammadi +4 more
2025American Journal of Clinical Dermatology4 citations Open access
Semantic Scholar
Bimekizumab
A. Blauvelt, A. Chiricozzi, B. Ehst
2020Current Dermatology Reports4 citations Open access
Semantic Scholar
15921 Absolute PASI response up to 52 weeks with brodalumab in patients with moderate to severe plaque psoriasis
A. Armstrong, B. Strober, B. Ehst, A. Jacobson
20204 citations
Semantic Scholar
A longitudinal atlas of human psoriatic skin reveals mechanisms of anti-IL-23 therapy in disrupting the type 17 inflammatory circuit
Run-Dong Jiang, A. Blauvelt, Linyun Shi, L. Tsoi +14 more
2026Immunity3 citations Open access
Semantic Scholar
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
Martina L. Porter, A. Martorell, C. J. Sayed, F. Bechara +19 more
2026Nature Medicine2 citations Open access
Semantic Scholar
71352 Efficacy of izokibep, a novel interleukin-17A inhibitor, in moderate to severe hidradenitis suppurativa: Week 32 results from a randomized, double-blind, placebo-controlled, multicenter, phase 3 study
K. Papp, F. Bechara, Martina L. Porter, Seth Forman +7 more
2026Journal of American Academy of Dermatology2 citations
Semantic Scholar
96 Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra: Subgroup Analyses of the Phase 3, ICONIC-LEAD Trial
J. Soung, C. Hong, B. Ehst, D. Mortazawi +6 more
2025Journal of Investigative Dermatology2 citations
Semantic Scholar
Reply to: Do interleukin 17 inhibitors increase risk of respiratory tract infections?
A. Blauvelt, B. Ehst
2020Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
191 Secukinumab treatment of individuals with psoriasis infected with hepatitis B and/or hepatitis C virus
S. Siegel, K. Winthrop, B. Ehst, A. Ortega-Loayza
20172 citations Open access
Semantic Scholar
Chronic Ulcerative Herpes Simplex Virus Infection of the Vulva
Kelly Griffith-Bauer, M. O'Hearn, B. Ehst
2012Case Reports in Dermatology2 citations Open access
Semantic Scholar
Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-week Phase 3b ADHAND Trial
B. Ehst, Richard B. Warren, Chih-Ho H. Hong, Dong-Hun Lee +6 more
2026SKIN The Journal of Cutaneous Medicine1 citations Open access
Semantic Scholar
Exploring Two New, Validated Disease-Specific Outcome Measures to Assess Severity of Chronic Hand Eczema: Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE) and Hand Eczema Symptom Diary (HESD)—A Podcast
R. Chovatiya, B. Ehst, J. Silverberg
2025Dermatologic Therapy1 citations Open access
Semantic Scholar
34613 Tapinarof cream 1% once daily (QD) for plaque psoriasis: Secondary efficacy outcomes from a long-term extension (LTE) trial
L. S. Gold, B. Ehst, L. Ferris, P. Brown +3 more
2022Journal of American Academy of Dermatology1 citations
Semantic Scholar
Comparative Infectious Risk of Immunosuppressive Therapies Used in Psoriasis
K. Winthrop, S. Siegel, Lang Chen, H. Yun +4 more
20161 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Bissonnette×5
Invite
R. Bissonnette — researcher profile on SciRah
A. Blauvelt×5
Invite
A. Blauvelt — researcher profile on SciRah
K. Winthrop×5
Invite
K. Winthrop — researcher profile on SciRah
M. Jenkins×3
Invite
M. Jenkins — researcher profile on SciRah

L. S. Stein Gold

×3

Invite

L. S. Stein Gold — researcher profile on SciRah

Invite

B. Strober — researcher profile on SciRah

Invite

K. Papp — researcher profile on SciRah

Invite

C. Hong — researcher profile on SciRah

Invite

P. Brown — researcher profile on SciRah

Invite

A. Deodhar — researcher profile on SciRah

Invite

J. Ku — researcher profile on SciRah

Andrew Blauvelt×3

Invite

Andrew Blauvelt — researcher profile on SciRah